Expression of OCT-4 and SOX-2 in bone marrow-derived human mesenchymal stem cells during osteogenic differentiation

Open Access Macedonian Journal of Medical Sciences

Volumn 4, Issue 1, 2016, Pages 9-16

  Matic, Igor ^a   Antunovic, Maja ^a   Brkic, Sime ^a   Josipovic, Pavle ^a   Mihalic, Katarina Caput ^a   Karlak, Ivan ^b   Ivkovic, Alan ^c   Marijanovic, Inga ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c University Hospital Sveti Duh   (Croatia)

Author keywords

Human mesenchymal stem cells; Osteodifferentiation; Pluripotency markers

Indexed keywords

ALKALINE PHOSPHATASE; BETA ACTIN; BONE SIALOPROTEIN; MESSENGER RNA; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

ARTICLE; BONE DEVELOPMENT; BONE MARROW DERIVED MESENCHYMAL STEM CELL; BONE MARROW OSTEOCLAST CELL; CELL CULTURE; CELL DIFFERENTIATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; GENE EXPRESSION; GLIOMA CELL LINE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; OSTEOGENIC DIFFERENTIATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 85027417814     PISSN: None     EISSN: 18579655     Source Type: Journal    
DOI: 10.3889/oamjms.2016.008     Document Type: Article

References (49)

1. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122:947–56. http://dx.doi.org/10.1016/j.cell.2005.08.020 PMid:16153702 PMCid:PMC3006442
2. Boiani M, Schöler HR. Regulatory networks in embryo-derived pluripotent stem cells. Nat Rev Mol Cell Biol. 2005;6:872–84. http://dx.doi.org/10.1038/nrm1744 PMid:16227977
3. Reim G, Brand M. Spiel-ohne-grenzen/pou2 mediates regional competence to respond to Fgf8 during zebrafish early neural development. Development. 2002;129:917–33. PMid:11861475
4. Palmieri SL, Peter W, Hess H, Schöler HR. Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev Biol. 1994;166:259–67. http://dx.doi.org/10.1006/dbio.1994.1312 PMid:7958450
5. Pesce M, Schöler HR. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells. 2001;19:271–8. http://dx.doi.org/10.1634/stemcells.19-4-271 PMid:11463946
6. Kim JH, Jee MK, Lee SY, et al. Regulation of adipose tissue stromal cells behaviors by endogenic Oct4 expression control. PLoS One. 2009;4. http://dx.doi.org/10.1371/journal.pone.0007166
7. Niwa H, Miyazaki J, Smith AG. Quantitative expression of Oct3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet. 2000;24:372–6. http://dx.doi.org/10.1038/74199 PMid:10742100
8. Tai M-H, Chang C-C, Kiupel M, et al. Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis. Carcinogenesis. 2005;26:495–502. http://dx.doi.org/10.1093/carcin/bgh321 PMid:15513931
9. Gidekel S, Pizov G, Bergman Y, Pikarsky E. Oct-3/4 is a dosedependent oncogenic fate determinant. Cancer Cell. 2003;4:361–70. http://dx.doi.org/10.1016/S1535-6108(03)00270-8
10. Monk M, Holding C. Human embryonic genes re-expressed in cancer cells. Oncogene. 2001;20:8085–91. http://dx.doi.org/10.1038/sj.onc.1205088 PMid:11781821
11. Greco SJ, Liu K, Rameshwar P. Functional similarities among genes regulated by OCT4 in human mesenchymal and embryonic stem cells. Stem Cells. 2007;25:3143–54. http://dx.doi.org/10.1634/stemcells.2007-0351 PMid:17761754
12. Kerkis I, Kerkis A, Dozortsev D, et al. Isolation and characterization of a population of immature dental pulp stem cells expressing OCT-4 and other embryonic stem cell markers. Cells Tissues Organs. 2006;184:105–16. http://dx.doi.org/10.1159/000099617 PMid:17409736
13. Beltrami AP, Cesselli D, Bergamin N, et al. Multipotent cells can be generated in vitro from several adult human organs (heart, liver, and bone marrow). Blood. 2007;110:3438–46. http://dx.doi.org/10.1182/blood-2006-11-055566 PMid:17525288
14. Lin G, Garcia M, Ning H, et al. Defining stem and progenitor cells within adipose tissue. Stem Cells Dev. 2008;17:1053–63. http://dx.doi.org/10.1089/scd.2008.0117 PMid:18597617 PMCid:PMC2865901
15. Fang X, Yoon J-G, Li L, et al. The SOX2 response program in glioblastoma multiforme: an integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics. 2011;12:11. http://dx.doi.org/10.1186/1471-2164-12-11 PMid:21211035 PMCid:PMC3022822
16. Girouard SD, Laga AC, Mihm MC, et al. SOX2 contributes to melanoma cell invasion. Laboratory Investigation. 2012:362–70. http://dx.doi.org/10.1038/labinvest.2011.188 PMid:22184093 PMCid:PMC3887365
17. Liu K, Lin B, Zhao M, et al. The multiple roles for Sox2 in stem cell maintenance and tumorigenesis. Cellular Signalling. 2013. p. 1264–71. http://dx.doi.org/10.1016/j.cellsig.2013.02.013 PMid:23416461 PMCid:PMC3871517
18. Masui S, Nakatake Y, Toyooka Y, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol. 2007;9:625–35. http://dx.doi.org/10.1038/ncb1589 PMid:17515932
19. Takahashi K, Yamanaka S. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell. 2006;126:663–76. http://dx.doi.org/10.1016/j.cell.2006.07.024 PMid:16904174
20. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, Jones SB, et al. Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA. 2003;100:13350–5. http://dx.doi.org/10.1073/pnas.2235735100 PMid:14595015 PMCid:PMC263817
21. Lengler J, Bittner T, Münster D, Gawad AEDA, Graw J. Agonistic and antagonistic action of AP2, Msx2, Pax6, Prox1 and Six3 in the regulation of Sox2 expression. Ophthalmic Res. 2005;37:301–9. http://dx.doi.org/10.1159/000087774 PMid:16118513
22. Pittenger MF. Multilineage Potential of Adult Human Mesenchymal Stem Cells. Science. 1999: 143–7. http://dx.doi.org/10.1126/science.284.5411.143 PMid:10102814
23. Dezawa M, Ishikawa H, Itokazu Y, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science. 2005;309:314–7. http://dx.doi.org/10.1126/science.1110364 PMid:16002622
24. Pierantozzi E, Gava B, Manini I, et al. Pluripotency regulators in human mesenchymal stem cells: expression of NANOG but not of OCT-4 and SOX-2. Stem Cells Dev. 2011;20:915–23. http://dx.doi.org/10.1089/scd.2010.0353 PMid:20879854
25. Greber B, Lehrach H, Adjaye J. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal. BMC Dev Biol. 2007;7:46. http://dx.doi.org/10.1186/1471-213X-7-46 PMid:17506876 PMCid:PMC1885259
26. Xu R-H, Sampsell-Barron TL, Gu F, et al. NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs. Cell Stem Cell. 2008;3:196–206. http://dx.doi.org/10.1016/j.stem.2008.07.001 PMid:18682241 PMCid:PMC2758041
27. Chambers I, Tomlinson SR. The transcriptional foundation of pluripotency. Development. 2009;136:2311–22. http://dx.doi.org/10.1242/dev.024398 PMid:19542351 PMCid:PMC2729344
28. Lengner CJ, Welstead GG, Jaenisch R. The pluripotency regulator Oct4: a role in somatic stem cells? 2008;7(6):725-8.
29. Lee MW, Kim DS, Yoo KH, et al. Human bone marrow-derived mesenchymal stem cell gene expression patterns vary with culture conditions. Blood Res [Internet]. 2013;48(2):107–14. http://dx.doi.org/10.5045/br.2013.48.2.107 PMid:23826579 PMCid:PMC3698395
30. Burns CE, Zon LI. Portrait of a stem cell. Dev Cell. 2002;3:612–4. http://dx.doi.org/10.1016/S1534-5807(02)00329-5
31. Romanov YA, Darevskaya AN, Merzlikina NV, Buravkova LB. Mesenchymal stem cells from human bone marrow and adipose tissue: Isolation, characterization, and differentiation potentialities. Bull Exp Biol Med. 2005;140:138–43. http://dx.doi.org/10.1007/s10517-005-0430-z PMid:16254640
32. Kang Q, Sun MH, Cheng H, et al. Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery. Gene Ther. 2004;11:1312–20. http://dx.doi.org/10.1038/sj.gt.3302298 PMid:15269709
33. Jayakumar P, Di Silvio L. Osteoblasts in bone tissue engineering. Proc Inst Mech Eng H. 2010;224:1415–40. http://dx.doi.org/10.1243/09544119JEIM821 PMid:21287829
34. Riekstina U, Cakstina I, Parfejevs V, et al. Embryonic stem cell marker expression pattern in human mesenchymal stem cells derived from bone marrow, adipose tissue, heart and dermis. Stem Cell Rev. 2009;5:378–86. http://dx.doi.org/10.1007/s12015-009-9094-9 PMid:20058201
35. Ono M, Kajitani T, Uchida H, et al. OCT4 expression in human uterine myometrial stem/progenitor cells. Hum Reprod. 2010;25:2059–67. http://dx.doi.org/10.1093/humrep/deq163 PMid:20576635
36. Arnold K, Sarkar A, Yram MA, et al. Sox2 + adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell. 2011;9:317–29. http://dx.doi.org/10.1016/j.stem.2011.09.001 PMid:21982232 PMCid:PMC3538360
37. Ji KH, Xiong J, Hu KM, Fan LX, Liu HQ. Simultaneous expression of Oct4 and genes of three germ layers in single cellderived multipotent adult progenitor cells. Annals of Hematology. 2008:431–8. http://dx.doi.org/10.1007/s00277-008-0470-3 PMid:18338169 PMCid:PMC2324127
38. Ezeh UI, Turek PJ, Reijo Pera RA, Clark AT. Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer. 2005;104:2255–65. http://dx.doi.org/10.1002/cncr.21432 PMid:16228988
39. Santagata S, Ligon KL, Hornick JL. Embryonic stem cell transcription factor signatures in the diagnosis of primary and metastatic germ cell tumors. Am J Surg Pathol. 2007;31:836–45. http://dx.doi.org/10.1097/PAS.0b013e31802e708a PMid:17527070
40. Bu Y, Cao D. The origin of cancer stem cells. Front Biosci (Schol Ed) [Internet]. 2012;4:819–30. http://dx.doi.org/10.2741/S302
41. Malik B. Cancer stem cells and resistance to chemo and radio therapy. Frontiers in Bioscience. 2012:2142. http://dx.doi.org/10.2741/E531
42. Zaehres H, Lensch MW, Daheron L, et al. High-efficiency RNA interference in human embryonic stem cells. Stem Cells [Internet]. 2005;23:299–305. http://dx.doi.org/10.1634/stemcells.2004-0252 PMid:15749924
43. Roche S, Richard MJ, Favrot MC. Oct-4, Rex-1, and Gata-4 expression in human MSC increase the differentiation efficiency but not hTERT expression. J Cell Biochem. 2007;101:271–80. http://dx.doi.org/10.1002/jcb.21185 PMid:17211834
44. Saxe JP, Tomilin A, Schöler HR, Plath K, Huang J. Posttranslational regulation of Oct4 transcriptional activity. PLoS One. 2009;4. http://dx.doi.org/10.1371/journal.pone.0004467
45. Wei F, Schöler HR, Atchison ML. Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem. 2007;282:21551–60. http://dx.doi.org/10.1074/jbc.M611041200 PMid:17525163
46. Liao B, Jin Y. Wwp2 mediates Oct4 ubiquitination and its own auto-ubiquitination in a dosage-dependent manner. Cell Res. 2010;20:332–44. http://dx.doi.org/10.1038/cr.2009.136 PMid:19997087
47. Seo E, Basu-Roy U, Zavadil J, Basilico C, Mansukhani A. Distinct Functions of Sox2 Control Self-Renewal and Differentiation in the Osteoblast Lineage. Molecular and Cellular Biology. 2011:4593–608. http://dx.doi.org/10.1128/MCB.05798-11 PMid:21930787 PMCid:PMC3209254
48. Basu-Roy U, Ambrosetti D, Favaro R, et al. The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death Differ. 2010;17:1345–53. http://dx.doi.org/10.1038/cdd.2010.57 PMid:20489730 PMCid:PMC2902624
49. Wang XQ, Ongkeko WM, Chen L, et al. Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway. Hepatology. 2010;52:528–39. http://dx.doi.org/10.1002/hep.23692 PMid:20683952